Table 3.
Prescription patterns for SLE patients followed by primary care physicians
| Drugs | Primary care physicians (n=92) % | Rheumatologists (n=665)% |
|---|---|---|
| NSAIDs | 100.0 | 99.4 |
| COX-2 inhibitors | 43.5 | 36.5 |
| Glucocorticoids | 45.7 | 51.6 |
| Hydroxychloroquine | 18.5 | 32.6* |
| Azathioprine | 3.3 | 8.0 |
| Cyclophosphamide | 0 | 1.1 |
| Methotrexate | 4.3 | 5.9 |
| Mycophenolate mofetil | 0 | 1.1 |
| Dapsone | 0 | .3 |
| Danazol | 0 | .9 |
| Cyclosporine | 0 | 0 |
SLE = systemic lupus erythematosus, NSAID = nonsteroidal antiinflammatory drug, COX-2 = cyclooxgenase-2.
*
p<.01